Shirley Longacre-Andre

Title: The Innovations of Shirley Longacre-Andre

Introduction

Shirley Longacre-Andre is a notable inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines against malaria. With a total of 2 patents, her work has garnered attention in both academic and research institutions.

Latest Patents

One of her latest patents involves a recombinant protein fabricated in a baculovirus system. This invention features a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite, which is infectious for humans. The C-terminal fragment remains anchored at the surface of the parasite during its penetration phase into human erythrocytes, facilitating an infectious cycle. This recombinant protein is applicable to the production of vaccines against malaria. Another patent also focuses on a recombinant protein containing the same C-terminal fragment of plasmodium MSP-1, emphasizing its potential in vaccine development.

Career Highlights

Shirley has worked with prestigious institutions such as New York University and the Institute Pasteur. Her research has contributed to advancements in understanding and combating malaria, a disease that poses significant health challenges worldwide.

Collaborations

Throughout her career, Shirley has collaborated with notable colleagues, including Charles W Roth and Faridabano Nato. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Shirley Longacre-Andre's innovative work in biotechnology and her dedication to developing vaccines against malaria highlight her importance in the field. Her contributions continue to inspire future research and advancements in public health.